Ledger.Open graph →

SEC Form D · Amendment · filed October 10, 2025

ECM Therapeutics, Inc

Offering

$40.0M

Sold

$35.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WARRENDALE, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Christine F. Sheehy · Warrendale, PAExec Paul F. Fagan · Warrendale, PAExec · Director Katie F. Collins · Warrendale, PAExec · Director George F. Hussey · Warrendale, PAExec Jenna F. Dziki · Warrendale, PAExec Lindsey F. Saldin · Warrendale, PAExec Stephen F. Badylak · Warrendale, PAExec · Director Jami S. O'Toole · Cambridge, MAExec · Director Vinay S. Mohta · Cambridge, MAExec Erin S. Osborn · Cambridge, MAExec · Director Stephen S. Ramsthaler · New York, NYExec OneFund Investments, LLC · San Francisco, CAExec Edward S. Rayner · Cambridge, MAExec · Director Peter Birch · Chatham, Ontario, CanadaExec Grady Collins · Austin, TXExec Romney Navarro · Austin, TXExec Herbert B. Stern · Palm Beach Gardens, FLExec · Director Douglas B. Wolf · Palm Beach Gardens, FLExec · Director Corey B. Siegel · Palm Beach Gardens, FLExec · Director Frank B. Peabody · Palm Beach Gardens, FLExec Thomas E. Mcgrath · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗